Table 3.
Lipid profile at day 1 | Septic shock (n = 20) | Non-septic patients (n = 20) | p |
---|---|---|---|
Total cholesterol, mmol/l | 2.1 [1.6–2.7] | 4.0 [3.1–4.8] | < 0.0001 |
mg/dl | 82 [62–105] | 156 [121–187] | |
LDL-C, mmol/l | 1.0 [0.8–1.6] | 2.3 [1.4–2.9] | 0.001 |
mg/dl | 39 [31–62] | 89 [54–112] | |
HDL-C (mmol/l) | 0.4 [0.3–0.7] | 1.3 [1.0–1.5] | <0.0001 |
mg/dl | 15 [12–27] | 50 [39–58] | |
Triglycerides, mmol/l | 0.9 [0.7–1.7] | 1.0 [0.7–1.2] | 0.69 |
mg/dl | 80 [62–150] | 88 [62–106] | |
Apolipoprotein-A1, mg/l | 916 [315–2543] | 2482 [1428–5518] | 0.05 |
Lipid profile at day 2 | Septic shock (n = 18) | Non-septic patients (n = 19) | p |
---|---|---|---|
Total cholesterol, mmol/l | 1.8 [1.2–2.9] | 3.2 [2.7–3.9] | 0.001 |
mg/dl | 70 [47–113] | 125 [105–152] | |
LDL-C, mmol/l | 0.9 [0.4–1.5] | 1.5 [1.1–2.2] | 0.02 |
mg/dl | 35 [15–58] | 58 [43–86] | |
HDL-C, mmol/l | 0.3 [0.2–0.6] | 1.0 [0.9–1.4] | <0.0001 |
mg/dl | 12 [8–24] | 39 [35–54] | |
Triglycerides, mmol/l | 1.4 [0.9–1.7] | 1.0 [0.8–1.1] | 0.16 |
mg/dl | 124 [80–150] | 88 [71–97] | |
Apolipoprotein-A1, mg/l | 787 [357–2234] | 1562 [965–3101] | 0.22 |
Lipid profile at day 7 | Septic shock (n = 15) | Non–septic patients (n = 12) | p |
---|---|---|---|
Total cholesterol, mmol/l | 2.7 [1.7–3.5] | 3.4 [2.2–3.8] | 0.29 |
mg/dl | 105 [66–136] | 132 [86–148] | |
LDL-C, mmol/l | 1.5 [0.9–2.0] | 1.8 [1.4–2.5] | 0.38 |
mg/dl | 58 [35–77] | 70 [54–97] | |
HDL-C, mmol/l | 0.4 [0.3–0.6] | 0.7 [0.5–1.2] | 0.04 |
mg/dl | 15 [12–24] | 27 [19–46] | |
Triglycerides, mmol/l | 1.3 [1.1–1.6] | 1.0 [0.9–1.5] | 0.25 |
mg/dl | 115 [97–142] | 88 [80–133] | |
Apolipoprotein-A1, mg/l | 1340 [391–1922] | 962 [508–3752] | 0.98 |
Results are expressed as medians (IQR). The statistical differences were analyzed by a Mann–Whitney test